Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Sight Sciences, Inc. (SGHT) Balance Sheet

As of 2026-06-30 (10-Q), Sight Sciences, Inc. (SGHT) reported total assets of $104.9M, total liabilities of $52.0M and shareholders' equity of $52.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $79.8M. Long-term debt: $30.6M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SGHTSight Sciences, Inc.Follow SGHT — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
495.2M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days
LineFY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
Latest
Jun 26
Trend
Cash and equivalents260.7185.0138.1120.492.079.8
Receivables8.715.114.310.89.711.4
Inventory3.56.17.86.37.85.7
Current assets277.0209.7162.9139.8112.7101.4
Total assets280.2213.1166.7142.8115.3104.9
Current liabilities13.517.812.315.511.020.5
Long-term debt32.733.331.739.440.330.6
Short-term debt0.00.02.20.00.010.1
Total liabilities48.153.046.455.351.452.0
Shareholders' equity232.1160.1120.287.563.952.9

USD millions · SEC XBRL

Sight Sciences, Inc. — questions

How much cash does Sight Sciences, Inc. have?
$79.8M in cash and cash equivalents as of 2026-06-30.
How much debt does Sight Sciences, Inc. have?
$30.6M of long-term debt and $10.1M due within a year as of 2026-06-30.
What are Sight Sciences, Inc.'s total assets?
$104.9M as of 2026-06-30.
What is Sight Sciences, Inc.'s shareholders' equity?
$52.9M as of 2026-06-30.

Every figure on this page comes from Sight Sciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.